Sanofi’s chief executive new president elect of EFPIA
November 7, 2012Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Chris Viehbacher, Sanofi
European pharma members body the EFPIA has announced that Sanofi’s chief executive Christopher Viehbacher is to stand as its new …
Takeda to buy Envoy Therapeutics
November 7, 2012Research and Development, Sales and Marketing CNS, Envoy, Parkinson's, Parkinsons, Takeda
Takeda Pharmaceutical Company has bought another private US firm, its second in as many months. The Japanese group is paying …
Pfizer backs new biotech firm
November 6, 2012Research and Development, Sales and Marketing Pfizer, Sandwich, Ziarco
Pfizer is one of the main backers of new biotech company Ziarco, launched by four of the manufacturer’s ex-employees. The …
Pharma manufacturing news in brief
November 6, 2012Manufacturing and Production Cytovance, DSM, Insipiration, Neolpharma, Paranta, Patheon
A round up of recent pharma manufacturing news, including an Ipsen/Inspiration facility up for sale, new contracts for Patheon, Cytovance …
First Northern Ireland director for ABPI announced
November 6, 2012Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, Colette Goldrick, Ireland
The ABPI has confirmed the appointment of Colette Goldrick as its new Northern Ireland director and as a member of …
MRC gives £7 million to new projects
November 6, 2012Sales and Marketing AstraZeneca, MRC, academics
The Medical Research Council (MRC) has handed out £7 million in funding for 15 research projects which will use a …
New plant positions Lilly for changing insulin market
November 6, 2012Manufacturing and Production Boehringer, insulin, lilly
Eli Lilly has unveiled plans for a $140 million expansion of its insulin plant in Indianapolis as it starts to …
Further US approval for Xarelto
November 5, 2012Sales and Marketing Eliquis, FDA, Pradaxa, Xarelto
US regulators have given the go-ahead to expand the indications for which Janssen Pharmaceuticals and Bayer HealthCare’s oral blood thinner …
Bayer to acquire Schiff Nutrition
November 4, 2012Sales and Marketing Bayer, mergers and acquisitions
Bayer HealthCare is to buy US-based vitamins and nutritional supplements firm Schiff Nutrition International for $1.2 billion.The deal is part …
Pfizer stumbles in third quarter
November 2, 2012Research and Development, Sales and Marketing Ian Read, Lipitor, Pfizer, Prevnar, Q3
Pfizer has experienced a worse than expected third quarter, due to disappointing sales of paediatric vaccine Prevnar and a surprise …
Sanofi criticised for multiple sclerosis manoeuvres
November 2, 2012Sales and Marketing Cancer, Lemtrada, MS, Sanofi
Sanofi is facing a backlash as it prepares its new MS treatment for the market. Lemtrada (alemtuzumab) has produced very …
COPA-DATA appoints new UK managing director
November 2, 2012Manufacturing and Production, Research and Development, Sales and Marketing COPA-DATA, Martyn Williams
Ergonomic process solutions firm COPA-DATA has appointed Martyn Williams as UK managing director with immediate effect. A qualified electronic engineer, …
Novartis says Canada and Switzerland lift vaccines ban
November 2, 2012Manufacturing and Production Canada, Novartis, Switzerland, vaccines
A temporary suspension on the distribution of flu vaccines made by Novartis has been lifted in Canada and Switzerland. The …
NICE hails ‘breakthrough’ skin cancer treatments
November 2, 2012Sales and Marketing BMS, NICE, Roche, Yervoy, Zelboraf
Two new skin cancer drugs have been recommended by NICE, which hailed the drugs as ‘breakthrough treatments’. Bristol-Myers Squibb’s Yervoy …
Meningitis probe extends to NECC sister company
November 1, 2012Manufacturing and Production NECC, ameridose, meningitis
A second compounding pharmacy has been drawn into the investigation into the meningitis outbreak that has killed 29 people in …
Mike Mallinson joins The Access Partnership
November 1, 2012Medical Communications, Sales and Marketing Mark Mallinson, The Access Partnership
Mike Mallinson has been appointed to lead communications firm The Access Partnership in the role of president. Mallinson is a …
GSK hit by European austerity again
November 1, 2012Sales and Marketing Europe, GSK, Q3, austerity
GlaxoSmithKline suffered in the third quarter as sales fell 5% due to generic competition and austerity measures in Europe.Exceptional sales …
Novartis to build $500 million biotech facility in Singapore
November 1, 2012Manufacturing and Production, Sales and Marketing Jimenez, M&P, Novartis, Singapore
Novartis is overseeing the construction of a biotechnology facility in Singapore that is the result of a $500m investment injection. …
Inspired Science appoints principal medical writer
October 31, 2012Medical Communications, Sales and Marketing Inspired Science, Peter Levantis
Med comms firm Inspired Science has announced the appointment of Dr Peter Levantis as principal medical writer. In this newly …
Diabetes softens generics blow for Sanofi
October 30, 2012Sales and Marketing Eloxatin, Plavix, Sanofi, diabetes, emerging markets, patent cliff
Sanofi has unveiled its results for the third quarter, with news that the damage done by patent expiries has not …
Latest content
Global coalition calls for stronger government action on COPD
Global health researchers call for more equitable partnerships
Liverpool launches £20m lab for infectious disease drug discovery
Circle Health Group expands into UK laboratory operations
FibroFind appoints Professor Andrew Fisher as Chief Medical Officer
